Locally ablatIVe thErapy for oLigo-progressive gastrOintestiNal maliGnancies (LIVELONG)

NCT06101277 · clinicaltrials.gov ↗

NA

Phase

RECRUITING

Status

300

Enrollment

OTHER

Sponsor class

Conditions

Esophageal Cancer
Small Bowel Cancer
Gastroesophageal-junction Cancer
Gastric Cancer
Colorectal Cancer
Appendiceal Cancer
Biliary Cancer
Gall Bladder Cancer
Intrahepatic Cholangiocarcinoma
Extrahepatic Cholangiocarcinoma
Oligoprogressive

Interventions

DEVICE: Ablative local therapy

Sponsor

University of California, Davis

Collaborators

[object Object]